Friday, 08 December 2023

Profound Medical Secures CPT Category 1 Codes for TULSA in Prostate Disease Treatment

AMA Grants Prostate Disease Treatment Breakthrough: Profound Medical Acquires CPT Category 1 Codes for TULSA

Profound Medical Corp., a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today that, with sponsorship and support from multiple physician specialty societies, the American Medical Association (“AMA”) has established three new Current Procedural Terminology (“CPT’) Category 1 codes for MRI-Monitored Transurethral Ultrasound Ablation (“TULSA”) of prostate tissue, performed using Profound’s TULSA-PRO system.

The first CPT Code describes the complete TULSA procedure when furnished by a single physician, such as a urologist. The other two CPT codes each describe a part of the TULSA procedure when TULSA is furnished by two physicians, such as a urologist in collaboration with a radiologist.

“We are honored that the TULSA application was approved by the AMA’s CPT Editorial Panel for Category I code status,” said Profound’s CEO and Chairman, Arun Menawat. “The establishment of these permanent codes specific to TULSA is a critical milestone for the broader adoption of the technology to treat prostate diseases in the United States. The application was independently sponsored and submitted without the direct involvement of Profound, which is a testament to the level of physician support for this new procedure. We would like to take this opportunity to thank the societies for their support, as well as the independent TULSA-PRO users who provided their invaluable feedback. Looking forward, as we continue to work toward realizing TULSA’s full potential for a broad spectrum of patients with prostate disease, we believe having multiple distinct CPT Category I codes for TULSA will give our physician users the flexibility to either do the entire procedure on their own, or collaborate and be reimbursed for their part of the service.”

The three new CPT Category 1 codes and their descriptors covering the TULSA procedure will be included in a future edition of the CPT Codebook and will be effective on January 1, 2025. In the meantime, U.S. hospitals performing the TULSA procedure on Medicare patients may continue to utilize HCPCS C code, C9734, established by the U.S. Centers for Medicare and Medicaid Services (CMS) for the Hospital Outpatient Prospective Payment System (“OPPS”). Effective January 1, 2023, reimbursement to a hospital billing under C9734 was increased to $13,048.

Published on : 05th June, 2023